| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-11 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-11 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-10 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.2 | 6e-10 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.21 | 8e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-09 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-09 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |